Tag Archives: NASDAQ:XBI

In Defense Of Early Stage Biotech IPOs
March 28, 2022

There’s “just too many early stage companies going public”, or so goes one of the most common lamentations about the current state of the biotech market. I’ve read a good deal of venting covering this theme, including comments about VCs

Leave a comment

Innovation Ecosystem: A Year Of Risk-Off Correlations
March 21, 2022

Misery loves company, and so it goes with the stock market for the innovation ecosystem these days. The general risk-off market environment has been crushing both the emerging tech and biotech sectors alike. Last year, generalists in many ways capitulated

Leave a comment

Biotech Bears: Jumping A Lower Bar Or A Higher One?
March 17, 2022

Biotech sentiment is super bearish today, as the sector has been crushed over the last year. There’s blood in the water, especially for small and mid-cap players, and everyone’s looking for what caused the carnage. There are many factors at

Leave a comment